Skip to main content
. 2025 Sep 25;20:834. doi: 10.1186/s13018-025-06269-y

Table 2.

HRs of muscle, adipose and bone parameters per SD decrease for FNF death risk

Unadjusted Adjusteda Adjustedb Adjustedc
HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
G.MaxM area (cm2) 0.91(0.85,0.97) < 0.01 0.93(0.86,1.01) 0.07 0.93(0.87,1.01) 0.08 0.93(0.86,1.00) 0.06
G.MaxM density (HU) 0.92(0.87,0.97) < 0.01 0.97(0.90,1.04) 0.34 0.96(0.90,1.03) 0.27 0.96(0.90,1.03) 0.27
G.Med/MinM area (cm2) 0.86(0.79,0.93) < 0.01 0.88(0.80,0.96) < 0.01 0.88(0.81,0.96) < 0.01 0.88(0.81,0.96) < 0.01
G.Med/MinM density (HU) 0.86(0.80,0.92) < 0.01 0.90(0.82,0.98) 0.01 0.89(0.82,0.97) 0.01 0.89(0.82,0.97) 0.01
MM area (cm2) 0.97(0.94,1.00) 0.02 0.99(0.95,1.03) 0.52 0.99(0.95,1.02) 0.42 0.99(0.95,1.02) 0.47
MM density (HU) 0.87(0.81,0.93) < 0.01 0.91(0.84,1.00) 0.04 0.91(0.84,0.99) 0.03 0.91(0.84,0.99) 0.03
MSAT area (cm2) 0.99(0.97,1.01) 0.15 0.99(0.97,1.01) 0.36 0.99(0.97,1.01) 0.30 0.99(0.97,1.01) 0.29
MSAT density (HU) 0.97(0.89,1.06) 0.50 0.96(0.88,1.04) 0.32 0.96(0.89,1.04) 0.34 0.96(0.88,1.05) 0.35
TH aBMD (mg/cm2) 1.00(0.99,1.000) 0.08 1.00(1.00,1.00) 0.85 1.00(1.00,1.00) 0.81 1.00(1.00,1.00) 0.73
FN aBMD (mg/cm2) 1.00(0.99,1000) 0.06 1.00(0.99,1.00) 0.64 1.00(0.99,1.00) 0.68 1.00(0.99,1.00) 0.52
TR aBMD (mg/cm2) 1.00(0.99,1.00) 0.14 1.00(1.00,1.01) 0.88 1.00(1.00,1.01) 0.98 1.000(1.00,1.01) 0.97
IT aBMD (mg/cm2) 1.00(0.99,1.00) 0.07 1.00(1.00,1.00) 0.77 1.00(1.00,1.00) 0.75 1.00(1.00, 1.00) 0.66
Parker Mobility Score 1 0.83(0.69,0.99) 0.04 NA NA NA NA NA NA
Parker Mobility Score 2 0.82(0.73,0.92) < 0.01 NA NA NA NA NA NA
ASA score 2.50(1.20,5.20) 0.02 NA NA NA NA NA NA
CCI 2.90(1.84,4.57) < 0.01 NA NA NA NA NA NA

* FNF, femoral neck fracture; aBMD, areal bone mineral density; ASA, American Society of Anesthesiologists; CCI, Charlson Comorbidity Index; HR, hazard ratio; SD, standard deviance; CI, confidence interval; G.MaxM, gluteus maximus muscle; G.Med/MinM, gluteus medius and minimus muscle; MM, midthigh muscle; MSAT, mid-thigh subcutaneous adipose tissue; TH, total hip; FN, femoral neck; TR, trochanter; IT, intertrochanter

Note: Parker Mobility Score 1: assessment obtained prior to hip fracture surgery; Parker Mobility Score 2: assessment within 3 months prior to death; Group without death: assessment of mobility prior to follow-up visit

aAdjusted for age, BMI, and ASA score

bAdjusted for age, BMI, and CCI

cAdjusted for age, BMI, and Parker Mobility Score prior to hip fracture surgery